Cargando…
MicroRNAs in Parkinson's disease and emerging therapeutic targets
Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder, with the clinical main symptoms caused by a loss of dopaminergic neurons in the substantia nigra, corpus striatum and brain cortex. Over 90% of patients with PD have sporadic PD and occur in people with n...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784336/ https://www.ncbi.nlm.nih.gov/pubmed/29323027 http://dx.doi.org/10.4103/1673-5374.221147 |
Ejemplares similares
-
MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
por: Martinez, Bridget, et al.
Publicado: (2017) -
Immunomodulators and microRNAs as neurorestorative therapy for ischemic stroke
por: Martinez, Bridget, et al.
Publicado: (2017) -
Blood microRNAs as potential diagnostic markers for hemorrhagic stroke
por: Martinez, Bridget, et al.
Publicado: (2017) -
Blood microRNAs as potential diagnostic and prognostic markers in cerebral ischemic injury
por: Martinez, Bridget, et al.
Publicado: (2016) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022)